Stable transfection and overexpression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB-231 cells
- PMID: 12908821
- DOI: 10.1023/A:1024520801262
Stable transfection and overexpression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB-231 cells
Abstract
The third isoform of metallothionein (MT-3) is overexpressed in some breast cancers and its expression is associated with a poor disease outcome. In the PC-3 prostate cancer cell line, MT-3 expression has been shown to inhibit cell growth and increase drug resistance. The goal of the present study was to determine if MT-3 overexpression would influence the growth of human breast cancer cell lines. To determine this, the coding sequence of the MT-3 gene was stably transfected into two estrogen receptor positive (MCF-7 and T-47D) and two estrogen receptor negative cell lines (Hs578T and MDA-MB-231) having no basal expression of MT-3. Cell growth was determined by counting DAPI-stained nuclei, cadmium resistance by the colony formation assay, MT mRNA expression by RT-PCR, and MT protein by immuno-blot. It was demonstrated that MCF-7 and Hs578T cells that overexpress the MT-3 gene were growth inhibited compared to untransfected cells. In contrast, T-47D and MDA-MB-231 cells that overexpress MT-3 were not growth inhibited. Stable transfection of the MT-1E gene had no effect on the growth of any of the four cell lines. It was also demonstrated that the overexpression of both MT-3 and MT-1E only increased the resistance of MCF-7 cells to Cd(+2). In all instances, stable transfection of the MT-3 or MT-1E gene had no effect on the expression of the other MT isoforms. The study shows that MT-3 can influence the growth of some breast cancer cell lines.
Similar articles
-
Clinicopathological significance of metallothioneins in breast cancer.Pathol Oncol Res. 2004;10(2):74-9. doi: 10.1007/BF02893459. Epub 2004 Jun 9. Pathol Oncol Res. 2004. PMID: 15188022 Review.
-
Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.Br J Cancer. 2000 Aug;83(3):319-23. doi: 10.1054/bjoc.2000.1276. Br J Cancer. 2000. PMID: 10917545 Free PMC article.
-
Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells.Prostate. 2002 Jul 1;52(2):89-97. doi: 10.1002/pros.10097. Prostate. 2002. PMID: 12111700
-
Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.Toxicol Sci. 2006 Oct;93(2):322-30. doi: 10.1093/toxsci/kfl065. Epub 2006 Jul 19. Toxicol Sci. 2006. PMID: 16854967
-
Relevance of breast cancer cell lines as models for breast tumours: an update.Breast Cancer Res Treat. 2004 Feb;83(3):249-89. doi: 10.1023/B:BREA.0000014042.54925.cc. Breast Cancer Res Treat. 2004. PMID: 14758095 Review.
Cited by
-
Role of metallothioneins in benign and malignant thyroid lesions.Thyroid Res. 2012 Dec 28;5(1):26. doi: 10.1186/1756-6614-5-26. Thyroid Res. 2012. PMID: 23273222 Free PMC article.
-
Clinicopathological significance of metallothioneins in breast cancer.Pathol Oncol Res. 2004;10(2):74-9. doi: 10.1007/BF02893459. Epub 2004 Jun 9. Pathol Oncol Res. 2004. PMID: 15188022 Review.
-
Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation.Mol Cancer. 2005 Dec 13;4:42. doi: 10.1186/1476-4598-4-42. Mol Cancer. 2005. PMID: 16351731 Free PMC article.
-
Quantitation of human metallothionein isoforms: a family of small, highly conserved, cysteine-rich proteins.Mol Cell Proteomics. 2014 Apr;13(4):1020-33. doi: 10.1074/mcp.M113.033373. Epub 2014 Feb 3. Mol Cell Proteomics. 2014. PMID: 24493013 Free PMC article.
-
Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression.PLoS One. 2015 May 1;10(5):e0124865. doi: 10.1371/journal.pone.0124865. eCollection 2015. PLoS One. 2015. PMID: 25933064 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous